ECEA identified the “Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)” Reactome pathway as equivalently changed by ketamine and imipramine and there is research linking this pathway with depression [22]. This evidence concerns the gene IGF1 and depressive symptom measurement.